Editors Choice

Obesity Treatment Is Not Just About Weight Loss

Amid all the excitement surrounding the new GLP-1-type anti-obesity medications and others in the pipeline, many people, including healthcare providers, are conflating weight loss with obesity treatment. But obesity treatment isn’t just about weight reduction or about one class of medications (no matter how promising!). In the words of a new consensus statement by the International Obesity Collaborative, “Obesity care is about health, not weight.”

Obesity care goes beyond mere body weight reduction in a number of ways, all of which tie back to an unwavering focus on improving patients’ health:

Comprehensive, individualized treatment

Obesity is a complex, multifactorial, relapsing chronic disease that requires a highly individualized treatment approach. Before starting a patient on an anti-obesity medication, we must develop a comprehensive, personalized education and treatment plan that takes into account all the specific factors contributing to that individual’s weight gain and those preventing weight loss (from physical activity and nutrition, to sleep patterns and stress, to previous weight loss experience, to other health conditions and medications). Treatment may include GLP-1 medications, but there’s no one-size-fits-all solution.

Careful prescribing

We call the medications anti-obesity medications rather than weight-loss drugs for a reason: they’re designed for long-term treatment of the chronic disease of obesity. We can’t just prescribe Wegovy or Zepbound and send patients on their way. These medications are generally well tolerated when prescribed appropriately, but not all patients with obesity are good candidates. We need to support those who are with dietary strategies and personalized titration schedules to minimize side effects, as well as education to identify early warning signs way before more serious adverse events occur.

Addressing comorbidities

Obesity leads to dysregulation in a variety of physiological pathways that can affect virtually every body system. Obesity is associated with more than 200 health conditions, including heart disease, hypertension, type 2 diabetes, osteoarthritis, sleep apnea and certain types of cancer, to name just a few. Treating obesity includes addressing these comorbidities. While it’s true that weight loss itself can lead to improvements in many of these weight-related health conditions, it’s not always a straightforward process. Individuals with obesity often have multiple comorbidities, and many are already taking multiple medications — creating additional variables and potential interactions to manage.

Health-related goals

Patients with obesity may present with specific weight goals they’d like to achieve, but as providers, we emphasize instead the importance of health outcomes, such as measurable improvements in metabolic health markers. The healthy lifestyle habits incorporated into the treatment plan underscore this focus, and a patient’s ability to decrease or discontinue other medications — for hypertension or diabetes, for example — often depends not only on the amount of weight lost, but also on these complementary lifestyle changes.

Support for long-term weight maintenance

Patients need to be aware that the initial weight loss period is only the first stage in a lifelong journey. Obesity is a chronic disease — one that we don’t yet have a cure for — which means that weight management requires long-term commitment. As clinicians, our job isn’t finished when our patients bring their weight down; we need to provide ongoing support to help them sustain the healthy behavior changes they’ve made, avoid medication discontinuation, and make adjustments and get back on track when they encounter the inevitable challenges along the way. Weight maintenance is often more difficult than weight loss, and patients frequently underestimate how much ongoing support they’ll need.

We’re thrilled to have so many new anti-obesity medications in our armamentarium — medications that are extraordinarily effective at helping individuals lose weight. But weight reduction is just part of the obesity treatment story. As clinicians, we need to make sure we’re looking beyond the number on the scale and delivering holistic, empathetic, evidence-based care tooptimize our patients’ overall health and well-being.

** I’m honored to be a member of the International Obesity Collaborative (IOC), a global initiative to address obesity internationally. Comprised of 12 leading obesity organizations, the IOC aims to raise awareness, share best practices, and implement effective interventions to treat obesity around the world.  We recently published the consensus statement: “Obesity Care vs. Weight Loss.” Stay tuned for more publications by the IOC.

Katherine Saunders, MD

Dr. Katherine H. Saunders is a physician entrepreneur and a leading expert in Obesity Medicine. She is on the cutting edge of effective and compassionate obesity treatment. Dr. Saunders practices at Intellihealth's clinical services affiliate, Flyte Medical, and teaches at Weill Cornell Medicine. Dr. Saunders received her undergraduate degree Phi Beta Kappa/Summa Cum Laude from Dartmouth College and her medical degree from Weill Cornell Medical College, where she became a member of the Alpha Omega Alpha Honor Medical Society. She completed her internship and residency training in Internal Medicine at NewYork-Presbyterian Hospital/Weill Cornell Medicine. Dr. Saunders was the first clinical fellow in Obesity Medicine at the Comprehensive Weight Control Center at Weill Cornell Medicine. Dr. Saunders is a diplomate of the American Board of Internal Medicine and the American Board of Obesity Medicine. She hosts the Weight Matters podcast with Dr. Louis Aronne, regularly speaks at international conferences, and publishes extensively on Obesity Medicine and weight management.

Recent Posts

Death Is Not A Failure

In my conversation with Dr. Elaine Chen of Rush University Medical Center, who is both…

18 hours ago

Executive action may actually drive up medicines prices

*This story will be updated as more details become available* President Trump’s executive order could…

3 days ago

Trump’s Drug Price Gambit: Cheaper for America, But Who Pays the Price?

Donald Trump is back at it, making big waves in the world of pharmaceuticals. On…

3 days ago

Cancer Isn’t Random: What 42% of Diagnoses Have in Common — and How You Can Lower Your Risk.

“The fault, dear Brutus, is not in our stars, but in ourselves…”— William Shakespeare, Julius Caesar.…

2 weeks ago

When Is Exercise Not Exercise, and Is That Good Enough?

Going for walks, dancing, and doing housework —although not technically exercises —any kind of movement counts toward your…

2 weeks ago

How Real-World Evidence Proves the Power of Patient Engagement

Data isn’t just an asset—it’s a trust marker. In life sciences, our credibility hinges on…

3 weeks ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More